Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

1737 ARTÍCULOS , VIENDO DEL 736 AL 750

Disturbances of Sleep and Alertness in Parkinson's Disease

Videnovic A.

Curr Neurol Neurosci Rep. 2018 Apr 19;18(6):29. doi: 10.1007/s11910-018-0838-2.

[Frequent neurological diseases associated with the restless legs syndrome]

Bartl M, Winkelmann J, Högl B, Paulus W, Trenkwalder C.

Nervenarzt. 2018 Oct;89(10):1156-1164. doi: 10.1007/s00115-018-0528-y.

Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised 2017)(§)

Winkelmann J, Allen RP, Högl B, Inoue Y, Oertel W, Salminen AV, Winkelman JW, Trenkwalder C, Sampaio C.

Mov Disord. 2018 Jul;33(7):1077-1091. doi: 10.1002/mds.27260. Epub 2018 May 14.

Lesson of the month 2: An unusual adverse reaction associated with pramipexole

Tashkent Y, Aiyappan V.

Clin Med (Lond). 2018 Jun;18(3):259-260. doi: 10.7861/clinmedicine.18-3-259.

[Sleep and wakefulness disorders in neurodegenerative diseases]

Yakovleva OV, Poluektov MG, Levin OS, Lyashenko EA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(4. Vyp. 2):83-91. doi: 10.17116/jnevro20181184283.

Restless Legs Syndrome and Parkinson Disease: A Causal Relationship Between the Two Disorders?

Ferini-Strambi L, Carli G, Casoni F, Galbiati A.

Front Neurol. 2018 Jul 24;9:551. doi: 10.3389/fneur.2018.00551. eCollection 2018.

Sleep in Parkinson's Disease with Impulse Control Disorder

Figorilli M, Congiu P, Lecca R, Gioi G, Frau R, Puligheddu M.

Curr Neurol Neurosci Rep. 2018 Aug 11;18(10):68. doi: 10.1007/s11910-018-0875-x.

Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease

Klepitskaya O, Liu Y, Sharma S, Sillau SH, Tsai J, Walters AS.

Neurology. 2018 Sep 11;91(11):e1013-e1021. doi: 10.1212/WNL.0000000000006162. Epub 2018 Aug 15.

[Increased frequency and spread of restlessness as the early manifestation of Parkinson's disease in a woman with restless legs syndrome]

Suzuki K, Matsubara T, Miyamoto M, Fujita H, Nakamura T, Hirata K.

Rinsho Shinkeigaku. 2018 Oct 24;58(10):617-621. doi: 10.5692/clinicalneurol.cn-001176. Epub 2018 Sep 29.

MANAGEMENT OF ENDOCRINE DISEASE: Impulse control disorders in patients with hyperpolactinemia treated with dopamine agonists: how much should we worry?

Barake M, Klibanski A, Tritos NA.

Eur J Endocrinol. 2018 Dec 1;179(6):R287-R296. doi: 10.1530/EJE-18-0667.

Modulation of specific components of sleep disturbances by simultaneous subthalamic and nigral stimulation in Parkinson's disease

Hidding U, Gulberti A, Pflug C, Choe C, Horn A, Prilop L, Braaß H, Fründt O, Buhmann C, Weiss D, Westphal M, Engel AK, Gerloff C, Köppen JA, Hamel W, Moll CKE, Pötter-Nerger M.

Parkinsonism Relat Disord. 2019 May;62:141-147. doi: 10.1016/j.parkreldis.2018.12.026. Epub 2018 Dec 28.

A Review of Scales to Evaluate Sleep Disturbances in Movement Disorders

Kurtis MM, Balestrino R, Rodriguez-Blazquez C, Forjaz MJ, Martinez-Martin P.

Front Neurol. 2018 May 29;9:369. doi: 10.3389/fneur.2018.00369. eCollection 2018.

Placebo and nocebo responses in other movement disorders besides Parkinson's disease: How much do we know?

Ferreira JJ, Trenkwalder C, Mestre TA.

Mov Disord. 2018 Aug;33(8):1228-1235. doi: 10.1002/mds.113.

Restless Legs Syndrome in NKX2-1-related chorea: An expansion of the disease spectrum

Iodice A, Carecchio M, Zorzi G, Garavaglia B, Spagnoli C, Salerno GG, Frattini D, Mencacci NE, Invernizzi F, Veneziano L, Mantuano E, Angriman M, Fusco C.

Brain Dev. 2019 Mar;41(3):250-256. doi: 10.1016/j.braindev.2018.10.001. Epub 2018 Oct 21.

New tricks for an old dog: A repurposing approach of apomorphine

Auffret M, Drapier S, Vérin M.

Eur J Pharmacol. 2019 Jan 15;843:66-79. doi: 10.1016/j.ejphar.2018.10.052. Epub 2018 Nov 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias